>Рынок автоматизированных клеточных культур в Азиатско-Тихоокеанском регионе, по продуктам (расходные материалы, инструменты), типу (бесконечные культуры клеточных линий, конечные культуры клеточных линий), применению (разработка лекарств, исследования стволовых клеток, регенеративная медицина , исследования рака, вакцины и т. д.), конечным пользователям (биотехнологические компании, исследовательские организации, академические научно-исследовательские институты и т. д.). Тенденции отрасли и прогноз до 2029 г.
Анализ и аналитика рынка автоматизированных клеточных культур в Азиатско-Тихоокеанском регионе
Отчет о рынке автоматизированных клеточных культур содержит подробную информацию о доле рынка, новых разработках и анализе продуктового портфеля, влиянии внутренних и локальных игроков рынка, анализирует возможности с точки зрения новых источников дохода, изменений в рыночных правилах, одобрений продуктов, стратегических решений, запусков продуктов, географических расширений и технологических инноваций на рынке. Чтобы понять анализ и рыночный сценарий, свяжитесь с нами для получения аналитического брифинга, наша команда поможет вам создать решение по влиянию на доход для достижения желаемой цели.
Ожидается, что рынок автоматизированных клеточных культур в Азиатско-Тихоокеанском регионе будет расти в прогнозируемый период с 2022 по 2029 год. По данным Data Bridge Market Research, рынок будет расти со среднегодовым темпом роста 9,8% в прогнозируемый период с 2022 по 2029 год и, как ожидается, достигнет 5 624,00 млн евро к 2029 году. Растущий спрос на технологию клеточного культивирования при производстве вакцин и широкое распространение методов клеточного культивирования в различных приложениях являются основными факторами, которые стимулировали спрос на рынке в прогнозируемый период .
|
Отчет Метрика |
Подробности |
|
Прогнозируемый период |
2022-2029 |
|
Базовый год |
2021 |
|
Исторические годы |
2020 (Можно настроить на 2019 - 2014) |
|
Количественные единицы |
Доход в млн. евро, объемы в единицах, цены в евро |
|
Охваченные сегменты |
По продукту (расходные материалы, инструменты), типу (бесконечные культуры клеточных линий, конечные культуры клеточных линий), применению (разработка лекарств, исследования стволовых клеток, регенеративная медицина , исследования рака, вакцины , другие), конечному пользователю (биотехнологические компании, исследовательские организации, академические научно-исследовательские институты, другие) |
|
Страны, охваченные |
Китай, Япония, Южная Корея, Индия, Австралия, Сингапур, Таиланд, Малайзия, Индия, Филиппины и остальные страны Азиатско-Тихоокеанского региона. |
|
Охваченные участники рынка |
Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG и другие |
Определение рынка автоматизированных клеточных культур в Азиатско-Тихоокеанском регионе
Automated cell culture systems are instruments that mechanically carries out the steps involved in growing and maintaining a cell culture. Useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery, an automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Automated cell culture systems can be capable of diluting samples, growing cultures in liquid with constant swirling, plating cultures, or placing cultures in wells. Increase in demand for 3D cell cultures, increasing collaboration among market players, and increasing outsourcing facilities are expected to provide a lucrative growth opportunity for the market. However, high cost of automated cell culture systems, and limitations associated with automated cell cultures are the factors expected to restraint the market growth in the forecast period.
Asia-Pacific Automated Cell Cultures Market Dynamics
This section deals with understanding the market drivers, opportunity, restraint, and challenge. All of this is discussed in detail below:
- Drivers
Increasing Demand For Cell Culture Technology In Vaccine Production
Cell culture is an essential tool for molecular and cellular biology research. Today, most biotechnology products primarily rely on mass culturing cell lines. Cell cultures have applications in diverse areas and serve as a model system for numerous research efforts.
An increase in funding from the government for cell-based research is significantly triggering the market's growth. In addition,cell culture techniques are widely being used as an alternative to current egg-based strategies for developing cell-based vaccines. Cell culture has potential applications in developing viral vaccines with increased communicable diseases and pandemic risk. Thus, cell culture technology is being extensively used in developing U.S. licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio.
Technological Advancements In Cell Culture Technology Systems
As the demand for advanced cell culture technologies in vaccine production, cancer research, and virology, among others, is increasing, certain technological developments are taking place in automated cell culture.
Thus, market players operating in the market adopt various technological developments in cell culture equipment to boost their business in various dimensions and lead to market growth. This factor could drive the Asia-Pacific automated cell cultures market growth.
- Restraint
High Cost Of Automated Cell Culture Systems
The cost of the product is the major setback for the market as it is expected to decrease the demand due to high cost. In the case of automated cell culture systems, the price is also high, and below the given instance will showcase the product's price.
The instruments and consumables-related products such as cell counters, reagents, buffers, and others have high prices, which shows that the cost of automated cell cultures is the primary factor expected to restrain the Asia-Pacific automated cell cultures market in the forecasted period.
- Opportunity
New Product Launches And Technology Developments
Pharmaceutical and biotechnology-driven companies are working towards developing and launching new products and technologies for automated cell culture advancement and making the treatment and diagnosis methods more reachable. This has also increased the demand for an automated cell culture market for 3D cell cultures. The development of new bioreactors, platforms, softwares has led to an advancement in the automated cell culture market and its growth.
The new products and technologies launched and worked upon create good opportunities for the Asia-Pacific automated cell cultures market. The new platforms with advanced technologies act as a footstep closer to the advancement of the market.
- Challenge
Development And Maintenance Of Expertise
Recruitment and retention of trained and qualified staff, staff development, capital budgets for equipment purchase, operating budget management, facility infrastructure, and change management all require proper attention for the growth and success of any market. Failure to meet needs in any of these areas can lead to a serious weakness that, if uncorrected, may compromise the credibility of a laboratory and create a situation that will be difficult to correct in the short term.
Testing and maintaining the level of expertise in testing laboratories is a tough task, and it needs high experience, which sometimes is not accessible, which causes the development process for a particular company to hinder. Thus it is anticipated to challenge the Asia-Pacific automated cell cultures market growth in the forecasted period.
Recent Developments
- In January 2021, a major breakthrough, HiGenoMB, the Molecular Biology section of Mumbai-based HiMedia Laboratories, has launched the quickest and the most leisurely 11 minutes automated RNA extraction protocol.
- In January 2021, FUJIFILM Corporation invested more than 200 billion yen (USD 2 Billion) to establish a new large-scale cell culture production site in the United States to accelerate the growth of its biopharmaceutical contract development and manufacturing business (CDMO).
Asia-Pacific Automated Cell Cultures Market Scope
Asia-Pacific automated cell cultures market is segmented into Product, Type, Application, and End User. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
Asia-Pacific Automated Cell Cultures Market, By Product
- Consumables
- Instruments
On the basis of product, the Asia-Pacific automated cell cultures market is segmented into consumables and instruments
Asia-Pacific Automated Cell Cultures Market, By Type
- Infinite Cell Line Cultures
- Finite Cell Line Cultures
On the basis of type, the Asia-Pacific automated cell cultures market is segmented into infinine cell line cultures and finite cell line cultures
Asia-Pacific Automated Cell Cultures Market, By Application
- Drug Development
- Stem Cell Research
- Regenerative Medicine
- Cancer Research
- Vaccines
- Other
On the basis of application, the Asia-Pacific automated cell cultures market is segmented into drug development, stem cell research, regenerative medicine, cancer research, vaccine and other.
Asia-Pacific Automated Cell Cultures Market, By End User
- Biotech Companies
- Research Organizations
- Academic Research Institutes
- Other
On the basis of end user, the Asia-Pacific automated cell cultures market is segmented into biotech companies, research organizations, academic research institutes and other.
Asia-Pacific Automated Cell Cultures Market Regional Analysis/Insights
The Asia-Pacific automated cell cultures market is analyzed and market size information is provided by Product, Type, Application, and End User.
The countries covered in this market report are China, Japan, South Korea, India , Australia, Singapore, Thailand, Malaysia, Indinesia, Philippines, and Rest of Asia-Pacific.
- In 2022, The Asia-Pacific automated cell cultures market is expected to grow due to increasing applications in stem cell research, vaccine production, regenerative medicines production, and drug discovery.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Automated Cell Cultures Market Share Analysis
Asia-Pacific automated cell cultures market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Asia-Pacific automated cell cultures market.
Основными игроками на рынке автоматизированных клеточных культур в Азиатско-Тихоокеанском регионе являются Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, Advanced Instruments, Benchmark scientific, Inc., BioSpherix, Ltd., Biotron Healthcare, Bulldog Bio, Cell Culture Company, LLC, CellGenix GmbH, ChemoMetec, Corning Incorporated, Cytiva (дочерняя компания Danahar Corporation), FUJIFILM Holdings America Corporation, Hemilton Company, Hitachi, Ltd., Kawasaki Heavy Industries, Ltd., HiMedia Laboratories, NanoEntek America, Inc., Nexcelom Bioscience LLC., PromoCell GmbH, RWD Life Science Co., LTD, Sartorius AG, Scientica Instrumentation, Inc., SHIBUYA CORPORATION, Sphere Fluidics Limited, Tecan Trading AG, Thrive Bioscience, Inc. и другие.
Методология исследования: Азиатско-Тихоокеанский рынок автоматизированных клеточных культур
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Рыночные данные анализируются и оцениваются с использованием рыночных статистических и когерентных моделей. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в рыночном отчете. Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Помимо этого, модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, анализ доли рынка компании, стандарты измерения, Азиатско-Тихоокеанский регион против регионального и анализ доли поставщиков. Пожалуйста, запросите звонок аналитика в случае дальнейшего запроса.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORK FOR ASIA PACIFIC AUTOMATED CELL CULTURES MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS
6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS
6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS
6.2 RESTRAINTS
6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS
6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES
6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT
6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS
6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS
6.3.3 INCREASING OUTSOURCING FACILITIES
6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE
6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES
7 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 CONSUMABLES
7.2.1 MEDIA
7.2.1.1 SERUM FREE MEDIA
7.2.1.2 CLASSICAL MEDIA & SALTS
7.2.1.3 STEM CELL CULTURE MEDIA
7.2.1.4 SPECIALTY MEDIA
7.2.2 BUFFERS AND SUPPLEMENTS
7.2.2.1 PLASMA
7.2.2.2 SERA
7.2.2.3 FETAL BOVINE SERA
7.2.2.4 ADULT BOVINE SERA
7.2.2.5 OTHERS ANIMAL SERA
7.2.3 REAGENTS
7.2.3.1 SUPPLEMENTS & GROWTH FACTORS
7.2.3.2 BUFFERS & CHEMICALS
7.2.3.3 CELL DISASSOCIATION REAGENTS
7.2.3.4 BALANCED SALT SOLUTIONS
7.2.3.5 ATTACHMENT & MATRIX FACTORS
7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS
7.2.3.7 CONTAMINATION DETECTION KITS
7.2.3.8 CRYOPROTECTIVE REAGENTS
7.2.3.9 OTHERS CELL CULTURE REAGENTS
7.2.4 ACCESSORIES
7.3 INSTRUMENTS
7.3.1 SUPPORTING EQUIPMENTS
7.3.1.1 CELL COUNTERS
7.3.1.2 IMAGE BASED CELL COUNTERS
7.3.1.3 FLOW CYTOMETERS
7.3.1.4 COULTER COUNTERS
7.3.1.5 CELL EXPANSION
7.3.1.6 LIQUID HANDLERS
7.3.1.7 OTHERS
7.3.2 BIOREACTORS
7.3.2.1 SINGLE USE BIOREACTORS
7.3.2.2 CONVENTIONAL BIOREACTORS
7.3.2.3 OTHERS
7.3.3 STORAGE EQUIPMENTS
7.3.3.1 REFRIGERATORS & FREEZERS
7.3.3.2 CRYOSTORAGE SYSTEMS
7.3.3.3 OTHERS
8 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY TYPE
8.1 OVERVIEW
8.2 INFINITE CELL LINE CULTURES
8.3 FINITE CELL LINE CULTURES
9 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DEVELOPMENT
9.3 STEM CELL RESEARCH
9.3.1 EMBRYONIC STEM CELLS
9.3.2 TISSUE-SPECIFIC STEM CELLS
9.3.3 MESENCHYMAL STEM CELLS
9.3.4 INDUCED PLURIPOTENT STEM CELLS
9.4 REGENERATIVE MEDICINE
9.4.1 STEM CELL THERAPY
9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS)
9.4.3 TISSUE ENGINEERING
9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS
9.5 CANCER RESEARCH
9.6 VACCINES
9.7 OTHERS
10 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY END USER
10.1 OVERVIEW
10.2 BIOTECH COMPANIES
10.3 RESEARCH ORGANIZATIONS
10.4 ACADEMIC RESEARCH INSTITUTES
10.5 OTHERS
11 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY REGION
11.1 ASIA-PACIFIC
11.1.1 CHINA
11.1.2 JAPAN
11.1.3 SOUTH KOREA
11.1.4 INDIA
11.1.5 AUSTRALIA
11.1.6 SINGAPORE
11.1.7 THAILAND
11.1.8 MALAYSIA
11.1.9 INDONESIA
11.1.10 PHILIPPINES
11.1.11 REST OF ASIA-PACIFIC
12 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
13 COMPANY PROFILE
13.1 LONZA
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.1.6 SWOT ANALYSIS
13.2 MERCK KGAA
13.2.1 COMPANY SNAPSHOT
13.2.2 RECENT FINANCIALS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.2.6 SWOT ANALYSIS
13.3 THERMO FISHER SCIENTIFIC INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 RECENT FINANCIALS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.3.6 SWOT ANALYSIS
13.4 BD
13.4.1 COMPANY SNAPSHOT
13.4.2 RECENT FINANCIALS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.4.6 SWOT ANALYSIS
13.5 EPPENDORF AG
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.5.6 SWOT ANALYSIS
13.6 ADVANCED INSTRUMENTS
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENTS
13.7 BENCHMARK SCIENTIFIC INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 BIOSPHERIX LTD.
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENTS
13.9 BIOTRON HEALTHCARE
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.1 BULLDOG-BIO, INC.
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.11 CELL CULTURE COMPANY, LLC
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENT
13.12 CELLGENIX GMBH
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 CHEMOMETEC
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 CORNING INCORPORATED
13.14.1 COMPANY SNAPSHOT
13.14.2 RECENT FINANCIALS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION)
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 FUJIFILM HOLDINGS AMERICA CORPORATION
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 HAMILTON COMPANY
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENTS
13.18 HITACHI, LTD.
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 KAWASAKI HEAVY INDUSTRIES, LTD.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENTS
13.2 HIMEDIA LABORATORIES
13.20.1 COMPANY SNAPSHOT
13.20.2 PRODUCT PORTFOLIO
13.20.3 RECENT DEVELOPMENTS
13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK)
13.21.1 COMPANY SNAPSHOT
13.21.2 PRODUCT PORTFOLIO
13.21.3 RECENT DEVELOPMENTS
13.22 NEXCELOM BIOSCIENCE LLC.
13.22.1 COMPANY SNAPSHOT
13.22.2 PRODUCT PORTFOLIO
13.22.3 RECENT DEVELOPMENTS
13.23 PROMOCELL GMBH
13.23.1 COMPANY SNAPSHOT
13.23.2 PRODUCT PORTFOLIO
13.23.3 RECENT DEVELOPMENTS
13.24 RWD LIFE SCIENCE CO LTD.
13.24.1 COMPANY SNAPSHOT
13.24.2 PRODUCT PORTFOLIO
13.24.3 RECENT DEVELOPMENTS
13.25 SARTORIUS AG
13.25.1 COMPANY SNAPSHOT
13.25.2 REVENUE ANALYSIS
13.25.3 PRODUCT PORTFOLIO
13.25.4 RECENT DEVELOPMENTS
13.26 SCIENTICA INSTRUMENTATION, INC.
13.26.1 COMPANY SNAPSHOT
13.26.2 PRODUCT PORTFOLIO
13.26.3 RECENT DEVELOPMENTS
13.27 SHIBUYA CORPORATION
13.27.1 COMPANY SNAPSHOT
13.27.2 RECENT FINANCIALS
13.27.3 PRODUCT PORTFOLIO
13.27.4 RECENT DEVELOPMENTS
13.28 SPHERE FLUIDICS LIMITED
13.28.1 COMPANY SNAPSHOT
13.28.2 PRODUCT PORTFOLIO
13.28.3 RECENT DEVELOPMENTS
13.29 TECAN TRADING AG
13.29.1 COMPANY SNAPSHOT
13.29.2 RECENT FINANCIALS
13.29.3 PRODUCT PORTFOLIO
13.29.4 RECENT DEVELOPMENT
13.3 THRIVE BIOSCIENCE, INC.
13.30.1 COMPANY SNAPSHOT
13.30.2 PRODUCT PORTFOLIO
13.30.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
Список таблиц
TABLE 1 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 2 ASIA PACIFIC CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 3 ASIA PACIFIC CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 4 ASIA PACIFIC MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 5 ASIA PACIFIC BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 6 ASIA PACIFIC REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCTS, 2020-2029 (EURO MILLION)
TABLE 7 ASIA PACIFIC INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 8 ASIA PACIFIC INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 9 ASIA PACIFIC SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 10 ASIA PACIFIC BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 11 ASIA PACIFIC STORAGE EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 12 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 13 ASIA PACIFIC INFINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 14 ASIA PACIFIC FINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 15 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 16 ASIA PACIFIC DRUG DEVELOPMENT IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 17 ASIA PACIFIC STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 18 ASIA PACIFIC STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 19 ASIA PACIFIC REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 20 ASIA PACIFIC REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 21 ASIA PACIFIC CANCER RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 22 ASIA PACIFIC VACCINES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 23 ASIA PACIFIC OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 24 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 25 ASIA PACIFIC BIOTECH COMPANIES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 26 ASIA PACIFIC RESEARCH ORGANIZATIONS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 27 ASIA PACIFIC ACADEMIC RESEARCH INSTITUTES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 28 ASIA PACIFIC OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 29 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET, BY COUNTRY, 2020-2029 (EURO MILLION)
TABLE 30 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 31 ASIA-PACIFIC CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 32 ASIA-PACIFIC MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 33 ASIA-PACIFIC BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 34 ASIA-PACIFIC REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 35 ASIA-PACIFIC INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 36 ASIA-PACIFIC SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 37 ASIA-PACIFIC BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 38 ASIA-PACIFIC STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 39 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 40 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 41 ASIA-PACIFIC STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 42 ASIA-PACIFIC REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 43 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 44 CHINA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 45 CHINA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 46 CHINA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 47 CHINA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 48 CHINA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 49 CHINA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 50 CHINA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 51 CHINA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 52 CHINA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 53 CHINA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 54 CHINA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 55 CHINA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 56 CHINA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 57 CHINA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 58 JAPAN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 59 JAPAN CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 60 JAPAN MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 61 JAPAN BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 62 JAPAN REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 63 JAPAN INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 64 JAPAN SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 65 JAPAN BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 66 JAPAN STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 67 JAPAN AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 68 JAPAN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 69 JAPAN STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 70 JAPAN REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 71 JAPAN AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 72 SOUTH KOREA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 73 SOUTH KOREA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 74 SOUTH KOREA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 75 SOUTH KOREA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 76 SOUTH KOREA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 77 SOUTH KOREA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 78 SOUTH KOREA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 79 SOUTH KOREA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 80 SOUTH KOREA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 81 SOUTH KOREA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 82 SOUTH KOREA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 83 SOUTH KOREA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 84 SOUTH KOREA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 85 SOUTH KOREA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 86 INDIA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 87 INDIA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 88 INDIA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 89 INDIA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 90 INDIA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 91 INDIA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 92 INDIA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 93 INDIA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 94 INDIA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 95 INDIA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 96 INDIA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 97 INDIA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 98 INDIA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 99 INDIA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 100 AUSTRALIA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 101 AUSTRALIA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 102 AUSTRALIA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 103 AUSTRALIA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 104 AUSTRALIA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 105 AUSTRALIA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 106 AUSTRALIA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 107 AUSTRALIA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 108 AUSTRALIA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 109 AUSTRALIA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 110 AUSTRALIA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 111 AUSTRALIA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 112 AUSTRALIA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 113 AUSTRALIA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 114 SINGAPORE AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 115 SINGAPORE CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 116 SINGAPORE MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 117 SINGAPORE BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 118 SINGAPORE REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 119 SINGAPORE INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 120 SINGAPORE SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 121 SINGAPORE BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 122 SINGAPORE STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 123 SINGAPORE AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 124 SINGAPORE AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 125 SINGAPORE STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 126 SINGAPORE REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 127 SINGAPORE AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 128 THAILAND AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 129 THAILAND CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 130 THAILAND MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 131 THAILAND BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 132 THAILAND REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 133 THAILAND INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 134 THAILAND SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 135 THAILAND BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 136 THAILAND STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 137 THAILAND AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 138 THAILAND AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 139 THAILAND STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 140 THAILAND REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 141 THAILAND AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 142 MALAYSIA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 143 MALAYSIA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 144 MALAYSIA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 145 MALAYSIA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 146 MALAYSIA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 147 MALAYSIA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 148 MALAYSIA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 149 MALAYSIA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 150 MALAYSIA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 151 MALAYSIA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 152 MALAYSIA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 153 MALAYSIA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 154 MALAYSIA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 155 MALAYSIA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 156 INDONESIA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 157 INDONESIA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 158 INDONESIA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 159 INDONESIA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 160 INDONESIA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 161 INDONESIA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 162 INDONESIA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 163 INDONESIA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 164 INDONESIA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 165 INDONESIA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 166 INDONESIA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 167 INDONESIA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 168 INDONESIA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 169 INDONESIA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 170 PHILIPPINES AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 171 PHILIPPINES CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 172 PHILIPPINES MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 173 PHILIPPINES BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 174 PHILIPPINES REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 175 PHILIPPINES INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 176 PHILIPPINES SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 177 PHILIPPINES BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 178 PHILIPPINES STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 179 PHILIPPINES AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 180 PHILIPPINES AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 181 PHILIPPINES STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 182 PHILIPPINES REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 183 PHILIPPINES AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 184 REST OF ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
Список рисунков
FIGURE 1 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE ASIA PACIFIC AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD
FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC AUTOMATED CELL CULTURES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC AUTOMATED CELL CULTURES MARKET
FIGURE 14 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021
FIGURE 15 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION)
FIGURE 16 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 17 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021
FIGURE 19 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION)
FIGURE 20 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 21 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021
FIGURE 23 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION)
FIGURE 24 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 25 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY END USER, 2021
FIGURE 27 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION)
FIGURE 28 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021)
FIGURE 31 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021)
FIGURE 32 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 ASIA-PACIFIC AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029)
FIGURE 35 ASIA PACIFIC AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
